GRN and frontotemporal dementia: Human-derived in vitro 2D and 3D cellular models have been developed, either derived from FTD-GRN patients or by lowering GRN levels with small interfering RNA [40, 205] or short-hairpin RNA (shRNA) [113, 206] in human cells.